# Roadmap V2 Real Result Master Review

- latest_review_date: `2026-07-20`
- research_restart_r2: `CONTINUE_EVIDENCE_CLOSURE`
- candidate_expansion_allowed: `false`
- new_parameter_search_allowed: `false`

- status: `NO_GROWTH_EDGE_FOUND`
- owner_recommendation: `N/A`
- paper_shadow_allowed: `false`
- production_allowed: `false`
- broker_action: `none`
- manual_review_required: `true`

## Required Answers

|Question|Answer|
|---|---|
|`1_real_run_1031_to_1048_complete`|`True`|
|`2_equal_risk_forward_aging_healthy`|`False`|
|`3_maturity_scoreboard_insufficient_constraints_preserved`|`True`|
|`4_controlled_growth_material_candidate_found`|`False`|
|`5_edge_survives_beta_adjustment`|`False`|
|`6_growth_candidate_component_reviewable`|`False`|
|`7_layer1_selector_remains_archived`|`True`|
|`8_next_minimum_task`|`continue_equal_risk_forward_aging_and_decide_whether_to_pause_growth`|

## R0～R2 Evidence Overlay（2026-07-20）

- R0 preflight/validator：`PASS`；
- dynamic-v3 walk-forward：80/80 fold 完整，但 test=20 reject + 20 review-required；
- robustness：9/9 neighbor、2/2 stress 完整，per-regime 因 `event_risk_high=15<20` 不完整；
- forward：16 ledger events，missing daily archive=5，20d/60d matured=0；
- R2：`CONTINUE_EVIDENCE_CLOSURE`，维持 candidate expansion pause。

## Source Statuses

|Source|Status|
|---|---|
|`equal_risk_growth_v2_real_cli_suite_summary`|`EQUAL_RISK_GROWTH_V2_REAL_RUN_WARN`|
|`equal_risk_forward_aging_live_health_summary`|`EQUAL_RISK_FORWARD_AGING_WARN`|
|`controlled_growth_v2_candidate_summary`|`CONTROLLED_GROWTH_V2_INCONCLUSIVE`|
|`controlled_growth_beta_adjusted_edge_review`|`EDGE_WEAK_AFTER_PENALTY`|
|`controlled_growth_period_drawdown_cost_triage`|`GROWTH_TRIAGE_COST_BLOCKED`|
|`controlled_growth_component_final_gate`|`NO_MATERIAL_GROWTH_EDGE`|
|`dual_track_owner_decision_pack`|`DUAL_TRACK_OWNER_DECISION_PACK_READY`|
